Big Pharma’s March Into Biotech Could Make Big Biologics A Big ’09 Theme

In 2009, some of the biggest new drugs might not technically be drugs at all. Major biologic products could dominate the upcoming year, largely thanks to big pharma's maturing interest in biotechnology